Clinical trial

Weight Loss in Adults Using Semaglutide (Real-world Study)

NCT07627074

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2026-05-12

PhaseN/A

Study timeline

Study start (actual)2026-05-12Date precision: day

Registry last updated2026-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Overweightunresolved

Obesityunresolved

Interventions

SemaglutideDRUG · verified · RxNorm: semaglutide

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

LondonUnited Kingdom1 SeattleWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07627074 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.